Literature DB >> 26091614

Preventing long-lasting fear recovery using bilateral alternating sensory stimulation: A translational study.

H Wurtz1, M El-Khoury-Malhame2, F H Wilhelm3, T Michael4, E M Beetz5, J Roques6, E Reynaud7, J Courtin1, S Khalfa8, C Herry9.   

Abstract

Posttraumatic stress disorder (PTSD) is a highly debilitating and prevalent psychological disorder. It is characterized by highly distressing intrusive trauma memories that are partly explained by fear conditioning. Despite efficient therapeutic approaches, a subset of PTSD patients displays spontaneous recurrence of traumatic memories after successful treatment. The development of animal behavioral models mimicking the individual variability in treatment outcome for PTSD patients represent therefore an important challenge as it allows for the identification of predicting factors of resilience or susceptibility to relapse. However, to date, only few animal behavioral models of long-lasting fear recovery have been developed and their predictive validity has not been tested directly. The objectives of this study were twofold. First we aimed to develop a simple animal behavioral model of long-lasting fear recovery based on auditory cued fear conditioning and extinction learning, which recapitulates the heterogeneity of fear responses observed in PTSD patients after successful treatment. Second we aimed at testing the predictive validity of our behavioral model and used to this purpose a translational approach based (i) on the demonstration of the efficiency of Eye Movement Desensitization and Reprocessing (EMDR) therapy to reduce conditioned fear responses in PTSD patients and (ii) on the implementation in our behavioral model of an electrical bilateral alternating stimulation of the eyelid which mimics the core feature of EMDR. Our data indicate that electrical bilateral alternating stimulation of the eyelid during extinction learning alleviates long-lasting fear recovery of conditioned fear responses and dramatically reduces inter-individual variability. These results demonstrate the face and predictive validity of our animal behavioral model and provide an interesting tool to understand the neurobiological underpinnings of long-lasting fear recovery.
Copyright © 2015 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Eye Movement Desensitization and Reprocessing; PTSD; bilateral alternating stimulation; fear conditioning; fear recovery

Mesh:

Year:  2015        PMID: 26091614     DOI: 10.1016/j.neuroscience.2015.06.012

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  4 in total

1.  Effects of heart rate variability biofeedback during exposure to fear-provoking stimuli within spider-fearful individuals: study protocol for a randomized controlled trial.

Authors:  Sarah K Schäfer; Frank R Ihmig; Karen A Lara H; Frank Neurohr; Stephan Kiefer; Marlene Staginnus; Johanna Lass-Hennemann; Tanja Michael
Journal:  Trials       Date:  2018-03-16       Impact factor: 2.279

2.  Bilateral Alternating Auditory Stimulations Facilitate Fear Extinction and Retrieval.

Authors:  Sarah Boukezzi; Catarina Silva; Bruno Nazarian; Pierre-François Rousseau; Eric Guedj; Camila Valenzuela-Moguillansky; Stéphanie Khalfa
Journal:  Front Psychol       Date:  2017-06-14

Review 3.  Role of the dorsal periaqueductal gray in posttraumatic stress disorder: mediation by dopamine and neurokinin.

Authors:  M L Brandão; T A Lovick
Journal:  Transl Psychiatry       Date:  2019-09-17       Impact factor: 6.222

4.  Assessing Mongolian gerbil emotional behavior: effects of two shock intensities and response-independent shocks during an extended inhibitory-avoidance task.

Authors:  Camilo Hurtado-Parrado; Camilo González-León; Mónica A Arias-Higuera; Angelo Cardona; Lucia G Medina; Laura García-Muñoz; Christian Sánchez; Julián Cifuentes; Juan Carlos Forigua; Andrea Ortiz; Cesar A Acevedo-Triana; Javier L Rico
Journal:  PeerJ       Date:  2017-11-13       Impact factor: 2.984

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.